Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression

被引：0
|
作者：
M Zhu
R Tang
S Doshi
K S Oliner
S Dubey
Y Jiang
R C Donehower
T Iveson
E Y Loh
Y Zhang
机构：
[1] Translational Sciences,
[2] Amgen Inc.,undefined
[3] Global Clinical Development,undefined
[4] Amgen Inc.,undefined
[5] Oncology,undefined
[6] Johns Hopkins Medical Center,undefined
[7] The Johns Hopkins University School of Medicine,undefined
[8] Medical Oncology,undefined
[9] University Hospital Southampton,undefined
来源：
British Journal of Cancer | 2015年 / 112卷
关键词：
rilotumumab; MET; exposure-response analysis; pharmacokinetics; gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 437
页数：8
相关论文
共 50 条
  • [1] Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression
    Zhu, M.
    Tang, R.
    Doshi, S.
    Oliner, K. S.
    Dubey, S.
    Jiang, Y.
    Donehower, R. C.
    Iveson, T.
    Loh, E. Y.
    Zhang, Y.
    BRITISH JOURNAL OF CANCER, 2015, 112 (03) : 429 - 437
  • [2] Rilotumumab Exposure-Response Relationship in Patients with Advanced or Metastatic Gastric Cancer
    Doshi, Sameer
    Gisleskog, Per Olsson
    Zhang, Yilong
    Zhu, Min
    Oliner, Kelly S.
    Loh, Elwyn
    Ruixo, Juan Jose Perez
    CLINICAL CANCER RESEARCH, 2015, 21 (11) : 2453 - 2461
  • [3] Potential role of rilotumumab in the treatment of gastric cancer
    Waddell, Tom
    Moorcraft, Sing Yu
    Cunningham, David
    IMMUNOTHERAPY, 2014, 6 (12) : 1243 - 1253
  • [4] Pharmacokinetics (PK) and exposure-response (ER) of rilotumumab (Rmab) in patients (pts) with small-cell lung cancer (SCLC)
    Zhang, Yilong
    Zheng, Jenny
    Tang, Rui
    Loh, Elwyn
    Dubey, Sarita
    Zhu, Min
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] UPDATED EFFICACY, BIOMARKER, AND EXPOSURE-RESPONSE DATA FROM A PHASE 2 STUDY OF RILOTUMUMAB (R) PLUS EPIRUBICIN, CISPLATIN, AND CAPECITABINE (ECX) IN GASTRIC (G) OR ESOPHAGOGASTRIC JUNCTION (EGJ) CANCER
    Davidenko, I.
    Iveson, T.
    Donehower, R. C.
    Tjulandin, S.
    Deptala, A.
    Jiang, Y.
    Zhu, M.
    Oliner, K. S.
    Dubey, S.
    Loh, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 230 - 230
  • [6] Analysis of ixabepilone exposure-response for neutropenia in patients with metastatic breast cancer
    Roy, A.
    Zhu, H.
    Cohen, M.
    Zhang, L.
    Pfister, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Role of the expression of c-Met receptor in the progression of gastric cancer
    Amemiya, Hideki
    Menolascino, Francisco
    Pena, Alix
    INVESTIGACION CLINICA, 2010, 51 (03): : 369 - 380
  • [8] Exposure-response (E-R) analysis of rilotumumab (R, AMG 102) plus epirubicin/cisplatin/capecitabine (ECX) in patients (pts) with locally advanced or metastatic gastric or esophagogastric junction (G/EGJ) cancer.
    Zhu, Min
    Tang, Rui
    Doshi, Sameer
    Oliner, Kelly S.
    Kathman, Steven
    Gisleskog, Per Olsson
    Dubey, Sarita
    Jiang, Yizhou
    Donehower, Ross C.
    Iveson, Timothy
    Loh, Elwyn
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Pharmacokinetic and exposure-response analysis of pertuzumab in patients with HER2-positive metastatic gastric or gastroesophageal junction cancer
    Kirschbrown, Whitney P.
    Wang, Bei
    Nijem, Ihsan
    Ohtsu, Atsushi
    Hoff, Paulo M.
    Shah, Manish A.
    Shen, Lin
    Kang, Yoon-Koo
    Alsina, Maria
    Girish, Sandhya
    Garg, Amit
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (03) : 539 - 550
  • [10] Development of a Copper Database for Exposure-Response Analysis
    Krewski, Daniel
    Chambers, Andrea
    Stern, Bonnie Ransom
    Aggett, Peter J.
    Plunkett, Laura
    Rudenko, Larisa
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2010, 73 (2-3): : 208 - 216
12345